Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Biotechnology

Editor-in-Chief

ISSN (Print): 1389-2010
ISSN (Online): 1873-4316

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Herbal Medicines - A Fruitful Approach to Periodic Illness Dysmenorrhoea: Evidence-based Review

Author(s): Keshav Bansal*, Sachin Sharma and Meenakshi Bajpai

Volume 25, Issue 2, 2024

Published on: 10 July, 2023

Page: [179 - 195] Pages: 17

DOI: 10.2174/1389201024666230623161113

Price: $65

Abstract

Dysmenorrhea (menstrual or periodic pain) is a discomfort that occurs during painful periods. It is the first and most prominent reason for female lower abdominal pain. Most adolescent girls consider it a curse due to the periodic occurrence of painful cramps and bleeding. The pathogenesis of painful periods is most likely because of increased prostanoids, notably prostaglandins, produced by the cyclooxygenase pathway (PGs). Misuse of synthetic medications leads to the development of medication resistance and deposits toxic residues in the body; thus, there is a critical need for safe and effective alternatives. In recent decades, herbal treatment approaches have found extensive applications in the treatment of various ailments. Herbal therapies are an alternate source, which include several bioactive chemicals, and recent improvements in our understanding of the value of herbal therapy methods have caused a sharp rise in their production. The main focus of this review was to study herbal treatment options; the recent studies conducted on herbal therapies and various experimental investigations on dysmenorrhea and herbal therapy methods have been studied, and randomized controlled trials and animal models have been discussed describing the anti-inflammatory properties of some potential herbal medicines that can be used as treatment options for dysmenorrhoea. This review aimed to present herbal treatments that can be used as alternative traditional synthetic medications and oral hormonal contraceptives in the treatment of painful menstruation.

« Previous Next »
Graphical Abstract

[1]
Guimarães, I.; Póvoa, A.M. Primary dysmenorrhea: assessment and treatment. Rev. Bras. Ginecol. Obstet., 2020, 42(8), 501-507.
[http://dx.doi.org/10.1055/s-0040-1712131] [PMID: 32559803]
[2]
Ferries-Rowe, E.; Corey, E.; Archer, J.S. Primary Dysmenorrhea. Obstet. Gynecol., 2020, 136(5), 1047-1058.
[http://dx.doi.org/10.1097/AOG.0000000000004096] [PMID: 33030880]
[3]
Gupta, R.; Gupta, J.; Kumar, D. Alternative approaches for rheumatoid arthritis management: future perspective, herbal, dietary, lifestyle, psychological, nutritional intervention and healthcare. J. Pharm. Res. Int., 2021, 33(54A), 342-363.
[http://dx.doi.org/10.9734/jpri/2021/v33i54A33756]
[4]
Gupta, R.; Sharma, S. herbal antibiotics: a review. bulletin of environment. Pharmacol Life Sci., 2020, 9(11), 136-142.
[5]
Itani, R.; Soubra, L.; Karout, S.; Rahme, D.; Karout, L.; Khojah, H.M.J. Primary dysmenorrhea: pathophysiology, diagnosis, and treatment updates. Korean J. Fam. Med., 2022, 43(2), 101-108.
[http://dx.doi.org/10.4082/kjfm.21.0103] [PMID: 35320895]
[6]
Gutman, G.; Nunez, A.T.; Fisher, M. Dysmenorrhea in adolescents. Curr. Probl. Pediatr. Adolesc. Health Care, 2022, 52(5), 101186.
[http://dx.doi.org/10.1016/j.cppeds.2022.101186] [PMID: 35523674]
[7]
Davis, A.R.; Westhoff, C.L. Primary dysmenorrhea in adolescent girls and treatment with oral contraceptives. J. Pediatr. Adolesc. Gynecol., 2001, 14(1), 3-8.
[http://dx.doi.org/10.1016/S1083-3188(00)00076-0] [PMID: 11358700]
[8]
Dawood, M.Y. Primary Dysmenorrhea. Obstet. Gynecol., 2006, 108(2), 428-441.
[http://dx.doi.org/10.1097/01.AOG.0000230214.26638.0c] [PMID: 16880317]
[9]
Schoep, M.E.; Adang, E.M.M.; Maas, J.W.M.; De Bie, B.; Aarts, J.W.M.; Nieboer, T.E. Productivity loss due to menstruation-related symptoms: a nationwide cross-sectional survey among 32 748 women. BMJ Open, 2019, 9(6), e026186.
[http://dx.doi.org/10.1136/bmjopen-2018-026186] [PMID: 31248919]
[10]
Morrow, C.; Naumburg, E.H. Dysmenorrhea. Prim. Care, 2009, 36(1), 19-32. vii.
[http://dx.doi.org/10.1016/j.pop.2008.10.004] [PMID: 19231600]
[11]
Friederich, M.A. Dysmenorrhoea.In lifting the curse of menstruation a feminist appraisal of the influence of menstruation on women’s lives New York: Routeledge; Golub, S., Ed.; Taylor and Francis: London, 2017, pp. 91-106.
[http://dx.doi.org/10.4324/9781315866116-5]
[12]
Harel, Z. Dysmenorrhea in adolescents and young adults: etiology and management. J. Pediatr. Adolesc. Gynecol., 2006, 19(6), 363-371.
[http://dx.doi.org/10.1016/j.jpag.2006.09.001] [PMID: 17174824]
[13]
Osayande, A.S.; Mehulic, S. Diagnosis and initial management of dysmenorrhea. Am. Fam. Physician, 2014, 89(5), 341-346.
[PMID: 24695505]
[14]
Weissman, A.M.; Hartz, A.J.; Hansen, M.D.; Johnson, S.R. The natural history of primary dysmenorrhoea: a longitudinal study. BJOG, 2004, 111(4), 345-352.
[http://dx.doi.org/10.1111/j.1471-0528.2004.00090.x] [PMID: 15008771]
[15]
Sachedin, A.; Todd, N. Dysmenorrhea, endometriosis and chronic pelvic pain in adolescents. J. Clin. Res. Pediatr. Endocrinol., 2020, 12(1), 7-17.
[http://dx.doi.org/10.4274/jcrpe.galenos.2019.2019.S0217] [PMID: 32041388]
[16]
Durain, D. Primary dysmenorrhea: assessment and management update. J. Midwifery Womens Health, 2004, 49(6), 520-528.
[http://dx.doi.org/10.1016/j.jmwh.2004.08.013] [PMID: 15544981]
[17]
Sanfilippo, J.; Erb, T. Evaluation and management of dysmenorrhea in adolescents. Clin. Obstet. Gynecol., 2008, 51(2), 257-267.
[http://dx.doi.org/10.1097/GRF.0b013e31816d2307] [PMID: 18463457]
[18]
Doty, E.; Attaran, M. Managing primary dysmenorrhea. J. Pediatr. Adolesc. Gynecol., 2006, 19(5), 341-344.
[http://dx.doi.org/10.1016/j.jpag.2006.06.005] [PMID: 17060018]
[19]
Iacovides, S.; Avidon, I.; Baker, F.C. What we know about primary dysmenorrhea today: a critical review. Hum. Reprod. Update, 2015, 21(6), 762-778.
[http://dx.doi.org/10.1093/humupd/dmv039] [PMID: 26346058]
[20]
Ruoff, G.; Lema, M. Strategies in pain management: new and potential indications for COX-2 specific inhibitors. J. Pain Symptom Manage., 2003, 25(2)(Suppl.), 21-31.
[http://dx.doi.org/10.1016/S0885-3924(02)00628-0] [PMID: 12604154]
[21]
French, L. Dysmenorrhea in Adolescents. Paediatr. Drugs, 2008, 10(1), 1-7.
[http://dx.doi.org/10.2165/00148581-200810010-00001] [PMID: 18162003]
[22]
Granot, M.; Yarnitsky, D.; Itskovitz-Eldor, J.; Granovsky, Y.; Peer, E.; Zimmer, E.Z. Pain perception in women with dysmenorrhea. Obstet. Gynecol., 2001, 98(3), 407-411.
[PMID: 11530120]
[23]
Ju, H.; Jones, M.; Mishra, G. The prevalence and risk factors of dysmenorrhea. Epidemiol. Rev., 2014, 36(1), 104-113.
[http://dx.doi.org/10.1093/epirev/mxt009] [PMID: 24284871]
[24]
Wang, L.; Yan, Y.; Qiu, H.; Xu, D.; Zhu, J.; Liu, J. Prevalence and risk factors of primary dysmenorrhea in students: a meta-analysis. Value Health, 2022, 2022, S1098-S3015.
[http://dx.doi.org/10.1016/j.jval.2022.03.023]
[25]
Ohde, S.; Tokuda, Y.; Takahashi, O.; Yanai, H.; Hinohara, S.; Fukui, T. Dysmenorrhea among Japanese women. Int. J. Gynaecol. Obstet., 2008, 100(1), 13-17.
[http://dx.doi.org/10.1016/j.ijgo.2007.06.039] [PMID: 17888923]
[26]
Wang, L.; Wang, X.; Wang, W.; Chen, C.; Ronnennberg, A.G.; Guang, W.; Huang, A.; Fang, Z.; Zang, T.; Wang, L.; Xu, X. Stress and dysmenorrhoea: a population based prospective study. Occup. Environ. Med., 2004, 61(12), 1021-1026.
[http://dx.doi.org/10.1136/oem.2003.012302] [PMID: 15550609]
[27]
Abenhaim, H.A.; Harlow, B.L. Live births, cesarean sections and the development of menstrual abnormalities. Int. J. Gynaecol. Obstet., 2006, 92(2), 111-116.
[http://dx.doi.org/10.1016/j.ijgo.2005.10.011] [PMID: 16376346]
[28]
Burnett, M.A.; Antao, V.; Black, A.; Feldman, K.; Grenville, A.; Lea, R.; Lefebvre, G.; Pinsonneault, O.; Robert, M. Prevalence of primary dysmenorrhea in Canada. J. Obstet. Gynaecol. Can., 2005, 27(8), 765-770.
[http://dx.doi.org/10.1016/S1701-2163(16)30728-9] [PMID: 16287008]
[29]
Harlow, B.L.; Missmer, S.A.; Cramer, D.W.; Barbieri, R.L. Does tubal sterilization influence the subsequent risk of menorrhagia or dysmenorrhea? Fertil. Steril., 2002, 77(4), 754-760.
[http://dx.doi.org/10.1016/S0015-0282(01)03253-8] [PMID: 11937129]
[30]
László, K.D. GyŐrffy, Z.; Ádám, S.; Csoboth, C.; Kopp, M.S. Work-related stress factors and menstrual pain: a nation-wide representative survey. J. Psychosom. Obstet. Gynaecol., 2008, 29(2), 133-138.
[http://dx.doi.org/10.1080/01674820701804423] [PMID: 18484442]
[31]
László, K.D.; Kopp, M.S. Effort-reward imbalance and overcommitment at work are associated with painful menstruation: results from the Hungarostudy Epidemiological Panel 2006. J. Occup. Environ. Med., 2009, 51(2), 157-163.
[http://dx.doi.org/10.1097/JOM.0b013e318197ca89] [PMID: 19209036]
[32]
Nohara, M.; Momoeda, M.; Kubota, T.; Nakabayashi, M. Menstrual cycle and menstrual pain problems and related risk factors among Japanese female workers. Ind. Health, 2010, (Aug), 1012100044.
[PMID: 21173526]
[33]
Patel, V.; Tanksale, V.; Sahasrabhojanee, M.; Gupte, S.; Nevrekar, P. The burden and determinants of dysmenorrhoea: a population-based survey of 2262 women in Goa, India. BJOG, 2006, 113(4), 453-463.
[http://dx.doi.org/10.1111/j.1471-0528.2006.00874.x] [PMID: 16489934]
[34]
Pawłowski, B. Prevalence of menstrual pain in relation to the reproductive life history of women from the Mayan rural community. Ann. Hum. Biol., 2004, 31(1), 1-8.
[http://dx.doi.org/10.1080/03014460310001602072] [PMID: 14742161]
[35]
Vivian, D.; Barnard, A. Prevalence and correlates of three types of pelvic pain in a nationally representative sample of Australian women. Med. J. Aust., 2009, 190(1), 47-48.
[http://dx.doi.org/10.5694/j.1326-5377.2009.tb02269.x] [PMID: 19266629]
[36]
Santer, M.; Warner, P.; Wyke, S. A Scottish postal survey suggested that the prevailing clinical preoccupation with heavy periods does not reflect the epidemiology of reported symptoms and problems. J. Clin. Epidemiol., 2005, 58(11), 1206-1210.
[http://dx.doi.org/10.1016/j.jclinepi.2005.02.026] [PMID: 16223665]
[37]
Tavallaee, M.; Joffres, M.R.; Corber, S.J.; Bayanzadeh, M.; Rad, M.M. The prevalence of menstrual pain and associated risk factors among Iranian women. J. Obstet. Gynaecol. Res., 2011, 37(5), 442-451.
[http://dx.doi.org/10.1111/j.1447-0756.2010.01362.x] [PMID: 21208343]
[38]
Unsal, A.; Tozun, M.; Aslan, G.; Ayranci, U.; Alkan, G. Evaluation of dysmenorrhea among women and its impact on quality of life in a region of western turkey. Pak. J. Med. Sci., 2010, 26(1), 142-147.
[39]
Coco, A.S. Primary dysmenorrhea. Am. Fam. Physician, 1999, 60(2), 489-496.
[PMID: 10465224]
[40]
Feng, X.; Wang, X. Comparison of the efficacy and safety of non-steroidal anti-inflammatory drugs for patients with primary dysmenorrhea: A network meta-analysis. Mol. Pain, 2018, 14(111)
[http://dx.doi.org/10.1177/1744806918770320] [PMID: 29587566]
[41]
Marjoribanks, J.; Proctor, M.L.; Farquhar, C.; Sangkomkamhang, U.S.; Derks, R.S. Nonsteroidal anti-inflammatory drugs for primary dysmenorrhoea. Cochrane Database Syst. Rev., 2003, (4), CD001751.
[PMID: 14583938]
[42]
McCOOL WF. W.F. Varney’s midwifery, 4th Edi; Jones and bartlett publishers, 2004.
[43]
Bulletin, A.P. ACOG Practice Bulletin No. 110: noncontraceptive uses of hormonal contraceptives. Obstet. Gynecol., 2010, 115(1), 206-218.
[http://dx.doi.org/10.1097/AOG.0b013e3181cb50b5] [PMID: 20027071]
[44]
Burnett, M.; Lemyre, M. No. 345-Primary Dysmenorrhea Consensus Guideline. J. Obstet. Gynaecol. Can., 2017, 39(7), 585-595.
[http://dx.doi.org/10.1016/j.jogc.2016.12.023] [PMID: 28625286]
[45]
Stewart, F.H.; Kaunitz, A.M.; LaGuardia, K.D.; Karvois, D.L.; Fisher, A.C.; Friedman, A.J. Extended use of transdermal norelgestromin/ethinyl estradiol: a randomized trial. Obstet. Gynecol., 2005, 105(6), 1389-1396.
[http://dx.doi.org/10.1097/01.AOG.0000160430.61799.f6] [PMID: 15932834]
[46]
Milsom, I.; Lete, I.; Bjertnaes, A.; Rokstad, K.; Lindh, I.; Gruber, C.J.; Birkhäuser, M.H.; Aubeny, E.; Knudsen, T.; Bastianelli, C. Effects on cycle control and bodyweight of the combined contraceptive ring, NuvaRing, versus an oral contraceptive containing 30 g ethinyl estradiol and 3 mg drospirenone. Hum. Reprod., 2006, 21(9), 2304-2311.
[http://dx.doi.org/10.1093/humrep/del162] [PMID: 16763008]
[47]
Dunn, N. Oral contraceptives and venous thromboembolism. BMJ, 2009, 339(aug13 2), b3164.
[http://dx.doi.org/10.1136/bmj.b3164] [PMID: 19679617]
[48]
Sergison, J.E.; Maldonado, L.Y.; Gao, X.; Hubacher, D. Levonorgestrel intrauterine system associated amenorrhea: a systematic review and metaanalysis. Am. J. Obstet. Gynecol., 2019, 220(5), 440-448.e8.
[http://dx.doi.org/10.1016/j.ajog.2018.12.008] [PMID: 30527945]
[49]
Hubacher, D.; Lopez, L.; Steiner, M.J.; Dorflinger, L. Menstrual pattern changes from levonorgestrel subdermal implants and DMPA: systematic review and evidence-based comparisons. Contraception, 2009, 80(2), 113-118.
[http://dx.doi.org/10.1016/j.contraception.2009.02.008] [PMID: 19631785]
[50]
Berenson, A.B.; Rahman, M.; Breitkopf, C.R.; Bi, L.X. Effects of depot medroxyprogesterone acetate and 20-microgram oral contraceptives on bone mineral density. Obstet. Gynecol., 2008, 112(4), 788-799.
[http://dx.doi.org/10.1097/AOG.0b013e3181875b78] [PMID: 18827121]
[51]
Hansen, S.O.; Knudsen, U.B. Endometriosis, dysmenorrhoea and diet. Eur. J. Obstet. Gynecol. Reprod. Biol., 2013, 169(2), 162-171.
[http://dx.doi.org/10.1016/j.ejogrb.2013.03.028] [PMID: 23642910]
[52]
Pattanittum, P.; Kunyanone, N.; Brown, J.; Sangkomkamhang, U.S.; Barnes, J.; Seyfoddin, V.; Marjoribanks, J. Dietary supplements for dysmenorrhoea. Cochrane Database Syst. Rev., 2016, 3(3), CD002124.
[PMID: 27000311]
[53]
Armour, M.; Ee, C.C.; Naidoo, D.; Ayati, Z.; Chalmers, K.J.; Steel, K.A.; de Manincor, M.J.; Delshad, E. Exercise for dysmenorrhoea. Cochrane Database Syst. Rev., 2019, 9(9), CD004142.
[PMID: 31538328]
[54]
Al-Husban, N.; Odeh, O.; Dabit, T.; Masadeh, A. The Influence of Lifestyle Variables on Primary Dysmenorrhea: A Cross-Sectional Study. Int. J. Womens Health, 2022, 14, 545-553.
[http://dx.doi.org/10.2147/IJWH.S338651] [PMID: 35444471]
[55]
Jo, J.; Lee, S.H. Heat therapy for primary dysmenorrhea: A systematic review and meta-analysis of its effects on pain relief and quality of life. Sci. Rep., 2018, 8(1), 16252.
[http://dx.doi.org/10.1038/s41598-018-34303-z] [PMID: 30389956]
[56]
Potur, D.C.; Kömürcü, N. The effects of local low-dose heat application on dysmenorrhea. J. Pediatr. Adolesc. Gynecol., 2014, 27(4), 216-221.
[http://dx.doi.org/10.1016/j.jpag.2013.11.003] [PMID: 24656704]
[57]
Arik, M.I.; Kiloatar, H.; Aslan, B.; Icelli, M. The effect of TENS for pain relief in women with primary dysmenorrhea: A systematic review and meta-analysis. Explore (NY), 2022, 18(1), 108-113.
[http://dx.doi.org/10.1016/j.explore.2020.08.005] [PMID: 32917532]
[58]
Elboim-Gabyzon, M.; Kalichman, L. Transcutaneous electrical nerve stimulation (tens) for primary dysmenorrhea: An Overview. Int. J. Womens Health, 2020, 12, 1-10.
[http://dx.doi.org/10.2147/IJWH.S220523] [PMID: 32021488]
[59]
Zhao, L.; Li, P. A survey of acupuncture treatment for primary dysmenorrhea. J. Tradit. Chin. Med., 2009, 29(1), 71-76.
[http://dx.doi.org/10.1016/S0254-6272(09)60035-2] [PMID: 19514193]
[60]
Smith, C.A.; Armour, M.; Zhu, X.; Li, X.; Lu, Z.Y.; Song, J. Acupuncture for dysmenorrhoea. Cochrane Database Syst. Rev., 2016, 4(4), CD007854.
[PMID: 27087494]
[61]
Proctor, M.; Farquhar, C. Diagnosis and management of dysmenorrhoea. BMJ, 2006, 332(7550), 1134-1138.
[http://dx.doi.org/10.1136/bmj.332.7550.1134] [PMID: 16690671]
[62]
Wyatt, S.N.; Banahan, T.; Tang, Y.; Nadendla, K.; Szychowski, J.M.; Jenkins, T.R. Effect of radiofrequency endometrial ablation on dysmenorrhea. J. Minim. Invasive Gynecol., 2016, 23(7), 1163-1166.
[http://dx.doi.org/10.1016/j.jmig.2016.08.825] [PMID: 27590567]
[63]
Darwish, M.; Atlantis, E.; Mohamed-Taysir, T. Psychological outcomes after hysterectomy for benign conditions: a systematic review and meta-analysis. Eur. J. Obstet. Gynecol. Reprod. Biol., 2014, 174(1), 5-19.
[http://dx.doi.org/10.1016/j.ejogrb.2013.12.017] [PMID: 24398028]
[64]
Bougie, O.; Suen, M.W.; Pudwell, J.; MacGregor, B.; Plante, S.; Nitsch, R.; Singh, S.S. Evaluating the prevalence of regret with the decision to proceed with a hysterectomy in women younger than age 35. J. Obstet. Gynaecol. Can., 2020, 42(3), 262-268.e3.
[http://dx.doi.org/10.1016/j.jogc.2019.08.006] [PMID: 31734156]
[65]
Jaleel, G.; Shaphe, M.A.; Khan, A.R.; Malhotra, D.; Khan, H.; Parveen, S.; Qasheesh, M.; Beg, R.A.; Chahal, A.; Ahmad, F.; Ahmad, M.F. Effect of exercises on central and endocrine system for pain modulation in primary dysmenorrhea. J. Lifestyle Med., 2022, 12(1), 15-25.
[http://dx.doi.org/10.15280/jlm.2022.12.1.15] [PMID: 35300040]
[66]
Morgan, P.J.; Kung, R.; Tarshis, J. Nitroglycerin as a uterine relaxant: a systematic review. J. Obstet. Gynaecol. Can., 2002, 24(5), 403-409.
[http://dx.doi.org/10.1016/S1701-2163(16)30403-0] [PMID: 12196860]
[67]
Moya, R.A.; Moisa, C.F.; Morales, F.; Wynter, H.; Ali, A.; Narancio, E. Transdermal glyceryl trinitrate in the management of primary dysmenorrhea. Int. J. Gynaecol. Obstet., 2000, 69(2), 113-118.
[http://dx.doi.org/10.1016/S0020-7292(00)00185-5] [PMID: 10802078]
[68]
Proctor, M.L.; Murphy, P.A. Herbal and dietary therapies for primary and secondary dysmenorrhoea. Cochrane Database Syst. Rev., 2001, (3), CD002124.
[PMID: 11687013]
[69]
Ziaei, S.; Faghihzadeh, S.; Sohrabvand, F.; Lamyian, M.; Emamgholy, T. A randomised placebo-controlled trial to determine the effect of vitamin E in treatment of primary dysmenorrhoea. BJOG, 2001, 108(11), 1181-1183.
[http://dx.doi.org/10.1111/j.1471-0528.2003.00279.x] [PMID: 11762659]
[70]
Jahangirifar, M.; Taebi, M.; Dolatian, M. The effect of Cinnamon on primary dysmenorrhea: A randomized, double-blind clinical trial. Complement. Ther. Clin. Pract., 2018, 33(33), 56-60.
[http://dx.doi.org/10.1016/j.ctcp.2018.08.001] [PMID: 30396627]
[71]
Vinodoni, R.; Hazel, A.A.; Sundaram, M.M.; Banumathi, V. Therapeutic potency of Siddha herbomineral preparation SiddhadhiEnnai on gynaecological diseases–a review. World J. Pharm. Pharm. Sci., 2018, 7(10), 969-979.
[72]
Adib Rad, H.; Basirat, Z.; Bakouei, F.; Moghadamnia, A.A.; Khafri, S.; Farhadi Kotenaei, Z.; Nikpour, M.; Kazemi, S. Effect of Ginger and Novafen on menstrual pain: A cross-over trial. Taiwan. J. Obstet. Gynecol., 2018, 57(6), 806-809.
[http://dx.doi.org/10.1016/j.tjog.2018.10.006] [PMID: 30545531]
[73]
Jose, B.; Jesy, E.J.; Nedumpara, R.J. Evaluation of the DPPH free radical scavenging activity of Wrightia tinctoria R. Br. leaf, bark and seed extracts. World J. Pharm. Res., 2014, 3(3), 5041-5048.
[74]
Liao, J.; Deng, J.; Chiu, C.; Hou, W.; Huang, S.; Shie, P. Anti-inflammatory activities of cinnamomum cassia constituents In vitro and In vivo. Evid. Based Compl. Alter. Med., 2012, 2022, 1-12.
[75]
Jeena, K.; Liju, V.B.; Kuttan, R. Antioxidant, anti-inflammatory and antinociceptive activities of essential oil from ginger. Indian J. Physiol. Pharmacol., 2013, 57(1), 51-62.
[PMID: 24020099]
[76]
Grzanna, R.; Lindmark, L.; Frondoza, C.G. Ginger--an herbal medicinal product with broad anti-inflammatory actions. J. Med. Food, 2005, 8(2), 125-132.
[http://dx.doi.org/10.1089/jmf.2005.8.125] [PMID: 16117603]
[77]
Kumar, A.; Singh, A.K. Trachyspermum Ammi (Ajwain): A Comprehensive Review. World J. Pharm. Res., 2021, 10(6), 724-736.
[78]
Umar, S.; Asif, M.; Sajad, M.; Ansari, M.M.; Hussain, U.; Ahmad, W.; Siddiqui, S.A.; Ahmad, S.; Khan, H.A. Anti-inflammatory and antioxidant activity of Trachyspermum ammi seeds in collagen induced arthritis in rats. Int. J. Drug Dev. & Res., 2012, 4(1), 210-219.
[79]
Vaishnav, M.; Makim, R. Evaluation of Effect of Trachyspermum ammi Extract on Primary Dysmenorrhoea. Annals of R.S.C.B., 2020, 24(2), 1233-1237.
[80]
Samadipour, E.; Rakhshani, M.H.; Kooshki, A.; Amin, B. Local Usage of Nigella sativa Oil as an Innovative Method to Attenuate Primary Dysmenorrhea: A Randomized Double-blind Clinical Trial. Oman Med. J., 2020, 35(5), e167.
[http://dx.doi.org/10.5001/omj.2020.109] [PMID: 32953142]
[81]
Hajhashemi, V.; Ghannadi, A.; Jafarabadi, H. Black cumin seed essential oil, as a potent analgesic and antiinflammatory drug. Phytother. Res., 2004, 18(3), 195-199.
[http://dx.doi.org/10.1002/ptr.1390] [PMID: 15103664]
[82]
Omidvar, S.; Esmailzadeh, S.; Baradaran, M.; Basirat, Z. Effect of fennel on pain intensity in dysmenorrhoea: A placebo-controlled trial. Ayu, 2012, 33(2), 311-313.
[http://dx.doi.org/10.4103/0974-8520.105259] [PMID: 23559811]
[83]
Heidarifar, R.; Mehran, N.; Heidari, A.; Koohbor, M. Mansourabad, MK Effect of Dill Anethum graveolens on the severity of primary dysmenorrhea in compared with mefenamic acid: A randomized, double-blind trial. J res med sci., 2014, 19(4), 326.
[84]
Kazemi, M. Phenolic profile, antioxidant capacity and anti-inflammatory activity of Anethum graveolens L. essential oil. Nat. Prod. Res., 2015, 29(6), 551-553.
[http://dx.doi.org/10.1080/14786419.2014.951934] [PMID: 25154406]
[85]
Pundarikakshudu, K.; Shah, D.; Panchal, A.; Bhavsar, G. Anti-inflammatory activity of fenugreek (Trigonella foenum-graecum Linn) seed petroleum ether extract. Indian J. Pharmacol., 2016, 48(4), 441-444.
[http://dx.doi.org/10.4103/0253-7613.186195] [PMID: 27756958]
[86]
Younesy, S.; Amiraliakbari, S.; Esmaeili, S.; Alavimajd, H.; Nouraei, S. Effects of fenugreek seed on the severity and systemic symptoms of dysmenorrhea. J. Reprod. Infertil., 2014, 15(1), 41-48.
[PMID: 24695380]
[87]
K, A.; Sultana, A.; Rahman, K. A single-blind randomized comparative study of Asafoetida vs Mefenamic acid in dysmenorrhea, associated symptoms and health-related quality of life. J. Herb. Med., 2017, 9, 21-31.
[http://dx.doi.org/10.1016/j.hermed.2017.06.003]
[88]
Bagheri, S.M.; Hedesh, S.T.; Mirjalili, A.; Dashti-R, M.H. Evaluation of anti-inflammatory and some possible mechanisms of antinociceptive effect of Ferula assa foetida oleo gum resin. J. Evid. Based Complementary Altern. Med., 2016, 21(4), 271-276.
[http://dx.doi.org/10.1177/2156587215605903] [PMID: 26427790]
[89]
Nazari, M.; Rostami-Moez, M.; Ebrahimi, F. The effect of fennel on pain relief in primary dysmenorrhea: A systematic review of clinical trials. Int. J. Epidemiol. Res., 2020, 7(1), 44-48.
[http://dx.doi.org/10.34172/ijer.2020.08]
[90]
Ostad, S.N.; Soodi, M.; Shariffzadeh, M.; Khorshidi, N.; Marzban, H. The effect of fennel essential oil on uterine contraction as a model for dysmenorrhea, pharmacology and toxicology study. J. Ethnopharmacol., 2001, 76(3), 299-304.
[http://dx.doi.org/10.1016/S0378-8741(01)00249-5] [PMID: 11448553]
[91]
Amirsalari, S.; Behboodi Moghadam, Z.; Taghizadeh, Z.; Jafar Abadi, M.N.; Sabaghzadeh Irani, P.; Goodarzi, S.; Ranjbar, H. The effect of garlic tablets on the endometriosis-related pains: a randomized placebo-controlled clinical trial. Evid. Based Complement. Alternat. Med., 2021, 2021, 1-8.
[http://dx.doi.org/10.1155/2021/5547058] [PMID: 34335819]
[92]
Jayanthi, M.K.; Dhar, M.; Jayanthi, M. Anti-inflammatory effects of Allium sativum (garlic) in experimental rats. Biomedicine (Taipei), 2011, 31(1), 84-89.
[93]
Bahrami, A.; Zarban, A.; Rezapour, H.; Agha Amini Fashami, A.; Ferns, G.A. Effects of curcumin on menstrual pattern, premenstrual syndrome, and dysmenorrhea: A triple‐blind, placebo‐controlled clinical trial. Phytother. Res., 2021, 35(12), 6954-6962.
[http://dx.doi.org/10.1002/ptr.7314] [PMID: 34708460]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy